Spots Global Cancer Trial Database for A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma
Official Title: A Phase 2, Multicenter, Open-Label Study of INCB050465, a PI3Kδ Inhibitor in Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
Study ID: NCT03126019
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Oncology Associates - Biltmore Cancer Center, Phoenix, Arizona, United States
Beverly Hills Cancer Center, Beverly Hills, California, United States
Synergy Hematology and Oncology Medical Associates, Los Angeles, California, United States
St. Joseph Heritage Healthcare, Santa Rosa, California, United States
American Institute of Research Corporate Office, Whittier, California, United States
Cancer Center of Central Connecticut, Southington, Connecticut, United States
Florida Cancer Specialists & Research Institute, Fort Myers, Florida, United States
Asclepes Research Centers, Spring Hill, Florida, United States
Clinical Trials of Swla Llc, Lake Charles, Louisiana, United States
Saint Agnes Hospital, Baltimore, Maryland, United States
Barbara Ann Karmanos Cancer Hospital, Detroit, Michigan, United States
Hattiesburg Clinic Hematology, Hattiesburg, Mississippi, United States
Saint Luke'S Hospital, Kansas City, Missouri, United States
Sarah Cannon Research Institute, Kansas City, Missouri, United States
Clinical Research Alliance, Inc., New Hyde Park, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Gabrail Cancer Center, Canton, Ohio, United States
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
Charleston Hematology Oncology Associates Pa, Charleston, South Carolina, United States
Tennessee Oncology, Nashville, Tennessee, United States
Renovatio Clinical Consultants Llc, Spring, Texas, United States
University of Washington, Seattle, Washington, United States
Western Health, St Albans, Victoria, Australia
Border Medical Oncology, Wodonga, Victoria, Australia
St Vincent'S Hospital Sydney, Darlinghurst, , Australia
Saint John Regional Hospital, St. John, New Brunswick, Canada
Sunnybrook Health Science Centre, Toronto, Ontario, Canada
Santa Cabrini Hospital, Montreal, Quebec, Canada
University Hospital Hradec Kralove, Hradec Kralove, , Czechia
Fakultni Nemocnice Ostrava, Ostrava, , Czechia
University Hospital Kralovkse Vinohrady, Prague, , Czechia
Fakultni Nemocnice V Motole, Praha 5, , Czechia
Univerzita Karlova V Praze 1. Lekarska Fakulta, Praha, , Czechia
Aalborg University Hospital, Aalborg, , Denmark
Odense Universitetshospital (Ouh) (Odense University Hospital), Odense C, , Denmark
Bag Arnoldstr. Dresden, Dresden, , Germany
University Medical Center Freiburg, Freiburg, , Germany
Universitatsmedizin Der Johannes Gutenberg-Universitat Mainz Iii, Mainz, , Germany
University Hospital Mannheim, Mannheim, , Germany
Semmelweis Egyetem, Budapest, , Hungary
National Institute of Oncology, Budapest, , Hungary
University of Debrecen, Debrecen, , Hungary
Somogy Medyei Kaposi Mor Oktato Korhaz, Kaposvar, , Hungary
Hillel Yafe Medical Center (Hymc), Hadera, , Israel
Rambam Medical Center, Haifa, , Israel
Laniado Hospital Hematology, Netanya, , Israel
Sheba Medical Center, Ramat Gan, , Israel
Tel Aviv Sourasky Medical Center, Tel Aviv-yafo, , Israel
Irccs Centro Di Riferimento Oncologico, Aviano, , Italy
Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari, , Italy
University of Bologna, Bologna, , Italy
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola, , Italy
Ospedale San Raffaele, Milano, , Italy
Fondazione Irccs Istituto Nazionale Dei Tumori, Milano, , Italy
A.O.U. Di Modena - Policlinico, Modena, , Italy
A.O.U. Federico Ii, Napoli, , Italy
Aou Maggiore Della Carita, Novara, , Italy
Ospedali Riuniti Villa Sofia Cervello, Palermo, , Italy
Sapienza University, Rome, , Italy
I.R.C.C.S. Casa Sollievo Della Sofferenza, San Giovanni Rotondo, , Italy
Aou Citta Della Salute E Della Scienza Di Torino, Torino, , Italy
San Bartolo Hospital, Vicenza, , Italy
Uniwersyteckie Centrum Kliniczne, Gdansk, , Poland
Pratia McM Krakow, Krakow, , Poland
State Hospital Opole, Opole, , Poland
Institute of Hematology and Transfusion Medicine, Warszawa, , Poland
Centrum Onkologii-Instytut Im. Marii Sklodowskiej-Curie, Warszawa, , Poland
Hospital de La Santa Creu I Sant Pau, Barcelona, , Spain
Hospital General Universitari Vall D Hebron, Barcelona, , Spain
Hgu Gregorio Maranon, Madrid, , Spain
Md Anderson Cancer Centre Madrid, Madrid, , Spain
Hospital Universitario Ramon Y Cajal, Madrid, , Spain
Hospital Universitario de La Paz, Madrid, , Spain
Hospital Universitario Hm Sanchinarro, Madrid, , Spain
Hospital Universitario Quironsalud Madrid, Madrid, , Spain
Hospital Universitario de Canarias, San Cristobal de La Laguna, , Spain
Hospital Universitario Virgen Macarena, Sevilla, , Spain
Hospital Universitario Virgen Del Rocio, Sevilla, , Spain
Karolinska University Hospital, Huddinge, Stockholm, , Sweden
Birmingham Heartlands Hospital, Birmingham, , United Kingdom
Northwick Park Hospital, London, , United Kingdom
Royal Hallamshire Hospital, Sheffield, , United Kingdom
The Royal Marsden Nhs Foundation Trust - Chelsea, Sutton, , United Kingdom
Contact Details
Name: Fred Zheng, MD, PhD
Affiliation: Incyte Corporation
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
